Apolipoprotein E (apoE) epsilon 4 allele frequency among Alzheimer's d
isease (AD) patients is increased compared to control subjects and is
influenced by the presence of other genetic factors and age at symptom
onset. We examined the relationship between age at AD symptom onset a
nd apoE by comparing the apoE epsilon 4 allele frequency of normal, el
derly control subjects (n = 107) to that in AD patients (n = 123), div
ided into four age-at-onset periods. Additionally, the distribution of
symptom onset ages of AD patients with and without apoE epsilon 4 all
eles was determined. We observed increased apoE epsilon 4 allele frequ
encies between the AD onset ages of 55 and 75 years, but not at the ex
tremes of onset ages (i.e. onset between 45 and 54 years of age and af
ter age 75). Our data suggests that having an apoE epsilon 4 allele in
creases the likelihood that AD patients will develop symptoms in the m
iddle range of onset ages. At the extremes of AD onset ages, non-apoE
factors, including other genetic factors and age, are more important d
eterminants of risk of developing AD.